You are here

  • Home
  • Archive
  • Volume 73, Issue Suppl 2
  • AB0235 Use of Rituximab Compared to Anti-TNF Agents as Second and Third Line Therapy in Patients with Rheumatoid Arthritis. A Report from the Rhumadata® Clinical Database and Registry

Citation Tools

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Abstracts accepted for publication. Rheumatoid arthritis - prognosis, predictors and outcome
AB0235 Use of Rituximab Compared to Anti-TNF Agents as Second and Third Line Therapy in Patients with Rheumatoid Arthritis. A Report from the Rhumadata® Clinical Database and Registry

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Choquette D, Raynauld J, Bessette L, et al
AB0235 Use of Rituximab Compared to Anti-TNF Agents as Second and Third Line Therapy in Patients with Rheumatoid Arthritis. A Report from the Rhumadata® Clinical Database and Registry
Annals of the Rheumatic Diseases 2014;73:881.